31.12.2014 Views

Anthony Antoniou - The Royal Marsden

Anthony Antoniou - The Royal Marsden

Anthony Antoniou - The Royal Marsden

SHOW MORE
SHOW LESS

Transform your PDFs into Flipbooks and boost your revenue!

Leverage SEO-optimized Flipbooks, powerful backlinks, and multimedia content to professionally showcase your products and significantly increase your reach.

<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong><br />

Colorectal cancer surgery<br />

and subsequent quality of<br />

life post resection<br />

Mr <strong>Anthony</strong> <strong>Antoniou</strong><br />

Senior Clinical Lecturer/ Honorary<br />

Consultant Colorectal Surgeon<br />

Upper and lower GI cancers - 16.07.2010


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

<strong>The</strong> surgical team<br />

Professor Lord Darzi, Professor of Surgery<br />

Mr Paris Tekkis, Reader in Surgery/ Honorary<br />

Consultant Surgeon<br />

Mr <strong>Anthony</strong> <strong>Antoniou</strong>, Senior Clinical Lecturer/<br />

Honorary Consultant Surgeon


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Why choose <strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong><br />

Early cancers<br />

– TEMs<br />

Colorectal carcinomas<br />

– traditional open<br />

– laparoscopic resections<br />

– ultra low resections and colo-anal anastamosis<br />

Synchronous colonic resections<br />

– HPB<br />

Recurrent cancer surgery


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Why choose <strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong><br />

Early cancers<br />

– TEMs<br />

Colorectal carcinomas<br />

– traditional open<br />

– laparoscopic resections<br />

– ultra low resections and colo-anal anastamosis<br />

Synchronous colonic resections<br />

– HPB<br />

Recurrent cancer surgery


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Trans Anal Endoscopic Microsurgery


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Indications for TEMs<br />

– Any benign rectal lesion above the dentate line<br />

within reach of the operating proctoscope<br />

– Selected T1 lesions<br />

– Selected T2 lesions with combined therapy


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Rectal cancer treatment options<br />

Local excision<br />

TME<br />

Disc excision of rectal wall<br />

Removal of all node bearing tissue<br />

Higher local recurrence rates<br />

Lower local recurrence rates<br />

Decreased operative morbidity<br />

Increased operative morbidity<br />

No functional disturbance<br />

Functional disturbance


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

TEM for benign disease<br />

Year Patients (N) Local<br />

Recurrence<br />

Rates (%)<br />

Menteges et al 1996 236 2<br />

Morshel et al 1998 226 3.6<br />

Nagy et al 1999 80 2.5<br />

Buess et al 2001 362 1.7<br />

Lloyd et al 2002 68 5.9<br />

Langer et l 2003 57 8.8<br />

Palma et al 2004 71 5<br />

Platell et al 2004 62 2.4<br />

Endreseth et al 2005 64 13<br />

Whitehouse et al 2006 146 4.8


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

TEM for T1 cancer<br />

Year Patient (N) Local Recurrence<br />

Rates (%)<br />

Buess et al 1988 12 0<br />

Buess et al 1992 25 4<br />

Winde et al 1996 24 4.2<br />

Smith et al 1996 30 10<br />

Langer et al 2001 16 12.5<br />

Demartines et al 2001 9 8.3<br />

Lee et al 2003 52 4.1<br />

Stipa et al 2006 23 8.6<br />

Floyd et al 2006 53 7.5<br />

Baatrup et al 2008 72 6


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

TEMs vs TME for T2 cancer<br />

• 70 patients with T2<br />

rectal cancer<br />

– 35 TEMs<br />

– 35 Laparoscopic<br />

resection<br />

• All received neoadjuvant<br />

treatment<br />

• Median follow up 84<br />

(72-96) months<br />

TEMs (%) TME (%)<br />

Local failure 5.7 2.8<br />

Distant<br />

metastases<br />

Local or<br />

Distant Failure<br />

2.8 2.8<br />

9 9<br />

Survival 94 94<br />

Lezoche et al Surg Endosc. 2008


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Recommended treatment plan


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Why choose <strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong><br />

Early cancers<br />

– TEMs<br />

Colorectal carcinomas<br />

– traditional open<br />

– laparoscopic resections<br />

– ultra low resections and colo-anal anastamosis<br />

Synchronous colonic resections<br />

– HPB<br />

Recurrent cancer surgery


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Why choose <strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong><br />

Early cancers<br />

– TEMs<br />

Colorectal carcinomas<br />

– traditional open<br />

– laparoscopic resections<br />

– ultra low resections and colo-anal anastamosis<br />

Synchronous colonic resections<br />

– HPB<br />

Recurrent cancer surgery


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Potential advantages of laparoscopic<br />

resection<br />

– Quicker return to<br />

function<br />

– Shorter stay<br />

– Decreased<br />

complications<br />

– Decreased pain


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Laparoscopic colon resection<br />

Positioning and ports


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Laparoscopic surgical resection


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Laparoscopy vs open surgery (colon cancer)<br />

Proven benefits<br />

– Quicker recovery from surgery<br />

– Lower wound infections<br />

– Lower respiratory problems<br />

– Huge benefit in elderly patient 40% less morbidity<br />

– Shorter length of Hospital Stay average 3-5 days<br />

– Quicker return to normal activity<br />

– Community nursing requirements 80%<br />

reduction<br />

– Lower hernia rates<br />

– Lower blood loss<br />

– Lower blood transfusion rate<br />

Conclusion of Trials<br />

N > 3000 patients


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Laparoscopic colorectal surgery<br />

Rectal cancer (survival RTC + CTs)<br />

Author Patients Follow-up Outcome<br />

Dulucq C<br />

Surg End 2005<br />

Morino M<br />

Surg Endo 2005<br />

Feliciotti F<br />

Surg Endo 2003<br />

Lezoche E<br />

Hepatogastro 2002<br />

Barlehner E<br />

Surg Endos 2005<br />

Delgado S, Lacy A<br />

Surg Endos 2004<br />

Poulin EC<br />

Surg Endos 2002<br />

218 5 years Same as open<br />

191 4 years Same as open<br />

124 4 years Same as open<br />

48 4 years Same as open<br />

194 4 years Same as open<br />

220


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Laparoscopy versus open surgery<br />

• Results the same as open surgery for colon cancer<br />

– Cancer survival<br />

– Lymph node harvest<br />

– Wound metastases<br />

– Anastomotic leak rate<br />

– Operative complication rate


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Why choose <strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong><br />

Early cancers<br />

– TEMs<br />

Colorectal carcinomas<br />

– traditional open<br />

– laparoscopic resections<br />

– ultra low resections and colo-anal anastamosis<br />

Synchronous colonic resections<br />

– HPB<br />

Recurrent cancer surgery


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Why choose <strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong><br />

Early cancers<br />

– TEMs<br />

Colorectal carcinomas<br />

– traditional open<br />

– laparoscopic resections<br />

– ultra low resections and colo-anal anastamosis<br />

Synchronous colonic resections<br />

– HPB<br />

Recurrent cancer surgery


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Ultra low anterior resection<br />

• 30% of cancers located in<br />

rectal area<br />

• patients with mid to low<br />

rectal cancers<br />

• sphincter preserving<br />

techniques<br />

– advent of stapling<br />

devices<br />

– improved surgical<br />

technique<br />

• acceptable oncological<br />

results and preserved<br />

sphincter function


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Ultra low anterior resection<br />

– increased rates of stool<br />

frequency, urgency, and<br />

incontinence due to the<br />

loss of the rectal reservoir<br />

– colonic reservoirs are<br />

superior in terms of<br />

functionality compared<br />

with SCAA at least within<br />

the first 2 years<br />

postoperatively


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Rectal cancer resections 2008 - 2010<br />

• Total 91 cases<br />

– 12 (13%) ultra low restoration of bowel continuity<br />

– 21 (23%) laparoscopic resection


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Why choose <strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong><br />

Early cancers<br />

– TEMs<br />

Colorectal carcinomas<br />

– traditional open<br />

– laparoscopic resections<br />

– ultra low resections and colo-anal anastamosis<br />

Synchronous colonic resections<br />

– HPB<br />

Recurrent cancer surgery


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Why choose <strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong><br />

Early cancers<br />

– TEMs<br />

Colorectal carcinomas<br />

– traditional open<br />

– laparoscopic resections<br />

– ultra low resections and colo-anal anastamosis<br />

Synchronous colonic resections<br />

– HPB<br />

Recurrent cancer surgery


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Presentation<br />

• within 2 years<br />

• depends on site<br />

• pain<br />

– perineum<br />

– buttock<br />

– leg<br />

• raised CEA<br />

• CT / MRI scan<br />

• colonoscopy


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Localised - perianastomotic


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Localised – connective tissue


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Localised – perineal recurrence


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Abdomino-perineal excision with sacrectomy


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Total pelvic exenteration with sacrectomy


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> – pelvic exenterations<br />

– 2006 - 2010<br />

– referrals - 96<br />

– n=58 (n=48 recurrent rectal cancer)<br />

– R0: 64%<br />

– R1: 16%<br />

– R2: 20%<br />

– sacrectomy: 40%<br />

– exenteration: 60%<br />

– EL: 35%<br />

– perineal flap: 35%<br />

– blood loss: 1500mls (250mls - 17l)


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Mortality and morbidity (n = 58)<br />

– any complications 50%<br />

– minor complications 57%<br />

– major complications 23%<br />

– intraoperative complications 9.1%<br />

– readmissions (90-day) 39%<br />

– Mortality 1.7%<br />

– length of stay (median; range) 14 days (3 – 86)


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

ICL – pelvic exenterations<br />

overall survival n=50 disease free survival n=40<br />

– overall survival – 46.8% 4 years<br />

– disease-free survival – 60% 4 years


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Years N= R0 Morbidity Mortality Survival<br />

Japan<br />

1983-2001 57 84% 58% 3.5% 23% 5yr<br />

Vienna 1987-2004 12 -- 42% 0% 17% 3yr<br />

Dutch 1994-1999 37 52% 82% 0% 41% 3yr<br />

Denver 1983- 45 73% 56% 4% 31% 5y<br />

Mayo 1990-1994 16 87% 50% 0% 48% 2y<br />

MSK 1987-2004 29 62% 59% 3% 47% 5yr<br />

Leeds<br />

(ASR) 1996-2006 40 62% 48% 2.5% 44% 3yr<br />

Imperial 2006-2010 58 65% 50% 1.7% 47% 4yr


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Multi-disciplinary team approach<br />

• oncologist / radiotherapist<br />

• surgeons:<br />

– colorectal, plastic, orthopaedic, urology,<br />

gynaecology<br />

• radiologist: diagnostic, interventional<br />

• anaesthetist: pain specialist, intensivist<br />

• nurses: stoma, nutrition, tissue viability<br />

• physiotherapy<br />

• pathologist


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Quality of life following<br />

colorectal surgery


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Quality of life following colorectal surgery<br />

Factors evaluated<br />

– bowel function<br />

– urinary function<br />

– sexual function<br />

– need for stoma<br />

Cornish et al. Ann Surg Oncol. 2007 Jul;14(7):2056-68


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

QoL APER vs AR<br />

– Avoiding a permanent stoma following rectal cancer<br />

excision is believed to improve quality of life (QoL)<br />

– meta-analysis of studies published between 1966<br />

and 2006<br />

– Quality of life outcomes measured by EORTC QLQ<br />

C30, CR38 and SF-36 for APER vs AR<br />

– outcomes for 1,443 patients from 11 studies, of<br />

whom 486 (33%) underwent APER<br />

– QoL assessments were made at periods of up to 2<br />

years following surgery


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

No Diff.<br />

AR<br />

AR<br />

APER


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Sexual and urinary outcomes after rectal<br />

cancer excision<br />

• assessment<br />

– at pre-op, 4mths, 8mths, then yearly for up to 5<br />

yr<br />

• Primary end points in sexual function<br />

– sexual activity<br />

– frequency of sexual intercourse per month<br />

– ability to achieve arousal<br />

– ability to attain orgasm<br />

– presence of dyspareunia<br />

Tekkis et al. Dis Colon Rectum. 2009 Jan;52(1):46-54


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Sexual and urinary outcomes after rectal<br />

cancer excision<br />

• Primary end points in urinary function<br />

– urinary urgency<br />

– urinary incontinence<br />

– nocturia<br />

– poor urinary stream<br />

– straining to pass urine<br />

– urinary retention<br />

– use of urinary catheter


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Study population<br />

AR APR p<br />

value (n=222) (n=73)<br />

mean age (yrs) 59.3 65.5 0.001<br />

median follow up (yrs) 3.28 2.95 NS<br />

radiotherapy 33.8% 60.3%


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Summary – sexual function<br />

• APR<br />

– less sexually active<br />

– intercourse<br />

– dyspareunia<br />

• radiotherapy dyspareunia<br />

• age ≥ 65 years sexual dysfunction across ALL<br />

domains


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Summary – urinary function<br />

• APR<br />

– urinary urgency<br />

– urinary incontinence<br />

– poor stream<br />

– urinary retention


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Conclusion<br />

– no differences in general QoL following APER vs AR<br />

– sexual and urinary outcomes should be considered<br />

when planning operative management<br />

– appropriate patient selection<br />

– individualization of care


<strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong> Upper and lower GI cancers - 16.07.2010<br />

Why <strong>The</strong> <strong>Royal</strong> <strong>Marsden</strong><br />

We have<br />

• Word leading Oncology Department<br />

• Surgical expertise<br />

– Trans- anal surgery<br />

– Laparoscopic surgery<br />

– Low rectal cancer surgery<br />

– Synchronous liver/ colorectal surgery<br />

– Recurrent cancer surgery<br />

• Excellence in endoscopy<br />

• Imaging resources<br />

• Nurse practitioner<br />

• Dedicated junior staff

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!